新生血管性年龄相关性黄斑变性患者白内障手术后的结局与预测因素:Fight Retinal Blindness! 项目
这项回顾性匹配病例对照研究评估了正在接受新生血管性年龄相关性黄斑变性(nAMD)治疗的患者白内障手术后的视力变化结局与预测因素。124例手术眼与372例匹配未手术眼相比,术后12个月视力平均增加10.6个字母(95%CI 7.8, 13.2; P<.001),手术眼视力高于对照眼(65.8 vs 61.3个字母,P=.018)。作者认为白内障手术对脉络膜新生血管(CNV)病变活动有轻度影响,但视力结局良好,并建议尽可能避免在开始nAMD治疗后6个月内行白内障手术。
要点
- nAMD治疗中行白内障手术眼术后12个月视力平均增加10.6个字母(95%CI 7.8, 13.2; P<.001)。
- 手术眼术后12个月视力高于匹配对照眼(65.8 vs 61.3个字母,P=.018)。
- 作者建议如有可能,应避免在开始nAMD治疗后6个月内行白内障手术。
核心结论
- 作者发现白内障手术对正在接受nAMD治疗眼的CNV病变活动有轻度影响的证据,但视力结局令人安心地良好。
- 作者建议如有可能,应避免在开始nAMD治疗后6个月内行白内障手术。
研究设计与样本
- 回顾性、匹配病例对照研究。
- 纳入124例接受白内障手术且自首次开始nAMD治疗以来被追踪的眼,与372例未手术的晶状体眼接受nAMD治疗者(每例3例对照)按白内障手术前治疗时长、基线视力、年龄和随访时长匹配。
主要发现
- 术后12个月视力平均增加10.6个字母(95%CI 7.8, 13.2; P<.001);26.0%视力增加≥3行,1.6%视力下降≥3行。
- 术后12个月手术眼平均(标准差)视力高于对照眼(65.8 [17.1] vs 61.3 [20.8]个字母,P=.018)。
- CNV病变评为活动的访视比例和平均注射次数在手术前后相似(分别为P=.506和P=.316),而对照组两者均下降,提示手术轻度增加了CNV病变的活动水平。
- 术前平均(标准差)视力在视力增加≥15个字母的眼低于增加0-14个字母的眼(40.2 [21.4] vs 62.1 [15.1],P<.001)。
- 在抗VEGF治疗前6个月内行白内障手术的患者更可能视力下降而非增加(视力下降20.8% vs 视力增加≥15个字母12.8%和增加0-14个字母4.4%,P=.023)。
临床怎么用
- 作者建议如有可能,应避免在开始nAMD治疗后6个月内行白内障手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate outcomes and predictive factors of visual acuity (VA) change after cataract surgery in patients being treated for neovascular age-related macular degeneration (nAMD). DESIGN: Retrospective, matched case-control study. METHODS: We studied eyes undergoing cataract surgery that had been tracked since they first started treatment for nAMD. These eyes were compared with a cohort of unoperated phakic eyes being treated for nAMD (3 per case) matched for treatment duration before cataract surgery, baseline VA, age, and length of follow-up. RESULTS: We included 124 patients that had cataract surgery and 372 matched controls. The mean (95% confidence interval) VA gained was 10.6 letters (7.8, 13.2; P < .001) 12 months after surgery; 26.0% had gained ≥3 lines and 1.6% had lost ≥3 lines of VA. Visual acuity (mean [standard deviation]) 12 months after surgery was higher in eyes that had cataract extraction compared with controls (65.8 [17.1] vs 61.3 [20.8] letters, respectively, P = .018). The proportion of visits where the choroidal neovascular (CNV) lesion was graded active and the mean number of injections were similar before and after surgery (P = .506 and P = .316, respectively), whereas both decreased in the control group, suggesting that surgery modestly increased the level of activity of the CNV lesion. Mean [SD] VA prior to surgery was lower in eyes that gained ≥15 letters compared with eyes that gained 0-14 letters (40.2 [21.4] vs 62.1 [15.1], P < .001). Patients undergoing cataract surgery within the first 6 months of anti-VEGF therapy were more likely to lose rather than gain vision (20.8% lost vision vs 12.8% and 4.4% gaining ≥15 or 0-14 letters respectively, P = .023). Age, receiving an injection at least 2 weeks before surgery, and the CNV lesion type had no discernible association with VA outcomes. CONCLUSIONS: We found evidence of a modest effect of cataract surgery on CNV lesion activity in eyes being treated for nAMD. Despite this, visual outcomes were reassuringly good. Cataract surgery within 6 months of starting treatment for nAMD should be avoided if possible.
引用
- Daien V, Nguyen V, Morlet N, et al. Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project. Am J Ophthalmol. 2018. PMID: 29550186. doi:10.1016/j.ajo.2018.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。